---
$id: https://graph.org.ai/products/commodity/51152037
$type: Product
source: UNSPSC
code: "51152037"
title: "Mephenoxalone"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mephenoxalone

**UNSPSC Code**: 51152037
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant with the molecular formula C11H13NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CZ87T54W8W, chemically known as 2-oxazolidinone, 5-((o-methoxyphenoxy)methyl)- but generally known as mephenoxalone, which bears US NIH Compound Identifier 6257. European Medicines Agency schedules Mephenoxalone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08747MIG. The term MEPHENOXALONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules mephenoxalone in its Anatomical Therapeutic Chemical (ATC) Classification. MEPHENOXALONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mephenoxalone under HS 29349990 and SITC 51579. As of Q4 2014, MEPHENOXALONE remains the US FDA Preferred Term for this commodity. Mephenoxalone bears US NLM identifiers UMLS ID C0065959 and NCI Concept Code C83930. SMILES: COC1=CC=CC=C1OCC2CNC(=O)O2.

